(369 days)
Not Found
No
The description details a microprocessor-based algorithm that performs calculations based on temperature data and user input (first day of bleeding) to predict ovulation. It does not mention any AI or ML techniques like neural networks, deep learning, or training/test sets for model development. The calculations appear to be deterministic based on predefined rules and temperature changes.
No.
It aids in ovulation prediction to aid in conception but is not intended for treating or diagnosing any disease or condition.
Yes
Explanation: The device is intended for measuring and recording basal body temperature (BBT) as an aid in ovulation prediction, which can be considered a diagnostic aid for fertility tracking. It helps detect and predict ovulation based on temperature changes.
No
The device description explicitly details hardware components: a Personal Sensor and a Reader, both made of silicone, with electromagnetic induction communication hardware and a microprocessor-based Reader with an LCD display.
Based on the provided information, the Fertility Focus OvuSense Fertility Monitor is an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The device is intended for "measuring and recording basal body temperature (BBT) as an aid in ovulation prediction to aid in conception". While it measures a physiological parameter (temperature), the purpose of this measurement is to provide information about a biological process (ovulation) to aid in a medical context (conception). This aligns with the definition of an IVD, which is used to examine specimens derived from the human body to provide information for diagnostic purposes. In this case, the "specimen" is the body temperature data, and the "diagnostic purpose" is aiding in the prediction of ovulation.
- Device Description: The device collects and processes physiological data (temperature) to provide information about a biological state (fertility). The algorithm calculates and displays information about ovulation and fertile periods. This processing and interpretation of biological data for diagnostic aid is characteristic of an IVD.
- Clinical Investigation: The performance study evaluated the device's ability to detect ovulation compared to traditional methods and a "gold standard" (ultrasound). This type of clinical evaluation to demonstrate the accuracy and reliability of the device in providing diagnostic information is typical for IVDs.
- Predicate Devices: The listed predicate devices, DuoFertility Monitor and Bioself 2000 Fertility Indicator, are also fertility monitors that likely fall under the IVD category. This further supports the classification of the OvuSense as an IVD.
While the device measures temperature in vivo (intra-vaginally), the analysis and interpretation of this data to provide information about ovulation and fertility is the key aspect that classifies it as an IVD. It's not just a simple thermometer; it's a system that uses physiological data to provide diagnostic aid related to a biological process.
N/A
Intended Use / Indications for Use
The Fertility Focus OvuSense Fertility Monitor (Fertility Focus OvuSense Fertility Monitor Starter Kit M009-US, which includes Reader M010-US and Personal Sensor M011) is intended for measuring and recording basal body temperature (BBT) as an aid in ovulation prediction to aid in conception (not to be used for contraception).
Product codes
LHD
Device Description
The Fertility Focus OvuSense Fertility Monitor is intended for measuring and recording core body temperature intra-vaginally on a nightly basis during the non-menstruating phases of the monthly female reproductive cycle. The Fertility Focus OvuSense Fertility Monitor consists of two components made of silicone - a Personal Sensor, which collects the data, and a Reader (with LCD display), which establishes a communication link to the Personal Sensor whereupon the data is transferred to the Reader.
Electromagnetic induction communications hardware transmits the stored temperature data from the Personal Sensor to the receiving device, the Reader, activated when the Sensor is placed on the Reader cradle and the Reader's dedicated download button is pressed. The microprocessor based Reader filters the overnight data, then calculates and stores the 25th percentile value, representative of the average basal (lowest) overnight temperature.
The Reader then displays these nightly temperature readings on a graph using a relative scale - the kev information for necessary calculations being the temperature changes relative to other recorded temperatures within a cycle for a particular user, and not absolute temperature value. At the start of the next cycle, indicated by the User inputting first day of the bleeding in the cycle, the Reader algorithm calculates the date of ovulation in the prior cycle, and uses this to predict the fertile period for the cycle which has just started. The Reader then displays fertility information in a verbal summary, including:
- An indication of the day ovulation occurred in the prior cycle, or if ovulation was not detected it displays this information instead.
- An indication whether the cycle length was within the expected normal parameters. -
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
intra-vaginally
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Over-The-Counter Use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Clinical investigation was conducted of the Fertility Focus OvuSense Fertility Monitor from 19 women who participated in a prospective study measuring 81 cycles over 3 months participation. The data from the primary endpoint of the trial described in the CIP demonstrated that the OvuSense Fertility Monitor system of ovulation detection provided a biological and statistically significant improvement in ovulation detection compared with the traditional method of oral temperature measurement. It demonstrated good linear agreement with the gold standard detection of ovulation using ultra-sound and an improved 95% confidence interval for the agreement.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
N/A
0
K122337 pg 1 of 5
fertility focus
This 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
| DATE: | July 30, 2013 | |
|---|---|---|
| APPLICANT: | Fertility Focus Ltd. | |
| Robert Milnes, CEO | ||
| Unit 19D, University of Warwick Science Park | ||
| Warwick Technology Park, Gallows Hill | ||
| Warwick, United Kingdom CV34 6UW | ||
| Tel: 044-1494-510272 | ||
| Email: robert.milnes@fertility-focus.com | AUG 0 6 2013 | |
| OFFICIAL | ||
| CORRESPONDENT | ||
| FOR THIS | ||
| SUBMISSION: | Penny Northcutt, RAC, FRAPS, CQA | |
| Regulatory Consultant for Fertility Focus | ||
| REGSolutions, LLC | ||
| Tel: 678-428-6978 | ||
| Fax: 678-513-0937 | ||
| Email: pennynorthcutt@theregsolutions.com | ||
| TRADE NAME: | Fertility Focus OvuSense Fertility Monitor | |
| CLASSIFICATION | ||
| NAME: | Device, fertility diagnostic, proceptive | |
| DEVICE | ||
| CLASSIFICATION | ||
| AND PRODUCT | ||
| CODE: | Pre-amendment, Unclassified | |
| Product Code: LHD | ||
| PREDICATE | ||
| DEVICE NAME: | DuoFertility Monitor, K102499 | |
| Bioself 2000 Fertility Indicator, K904211 |
SUBSTANTIAL EQUIVALENCE:
The Fertility Focus OvuSense Fertility Monitor is substantially equivalent to the legally marketed DuoFertility Monitor (K102499) and the Bioself 2000 Fertility Indicator (K904211). The Fertility Focus OvuSense Fertility Monitor has similar indications for use statements, principles of operation, and technological characteristics as the predicate devices.
1
DESCRIPTION OF THE DEVICE:
The Fertility Focus OvuSense Fertility Monitor is intended for measuring and recording core body temperature intra-vaginally on a nightly basis during the non-menstruating phases of the monthly female reproductive cycle. The Fertility Focus OvuSense Fertility Monitor consists of two components made of silicone - a Personal Sensor, which collects the data, and a Reader (with LCD display), which establishes a communication link to the Personal Sensor whereupon the data is transferred to the Reader.
Electromagnetic induction communications hardware transmits the stored temperature data from the Personal Sensor to the receiving device, the Reader, activated when the Sensor is placed on the Reader cradle and the Reader's dedicated download button is pressed. The microprocessor based Reader filters the overnight data, then calculates and stores the 25th percentile value, representative of the average basal (lowest) overnight temperature.
The Reader then displays these nightly temperature readings on a graph using a relative scale - the kev information for necessary calculations being the temperature changes relative to other recorded temperatures within a cycle for a particular user, and not absolute temperature value. At the start of the next cycle, indicated by the User inputting first day of the bleeding in the cycle, the Reader algorithm calculates the date of ovulation in the prior cycle, and uses this to predict the fertile period for the cycle which has just started. The Reader then displays fertility information in a verbal summary, including:
- An indication of the day ovulation occurred in the prior cycle, or if ovulation was not detected it displays this information instead.
- An indication whether the cycle length was within the expected normal parameters. -
INTENDED USE/INDICATIONS FOR USE:
The Fertility Focus OvuSense Fertility Monitor (Fertility Focus OvuSense Fertility Monitor Starter Kit M009-US, which includes Reader M010-US and Personal Sensor M011) is intended for measuring and recording basal body temperature (BBT) as an aid in ovulation prediction to aid in conception (not to be used for contraception).
TECHNOLOGICAL CHARACTERISTICS:
OvuSense Fertility Monitor and DuoFertility Monitor have the following similar and substantially equivalent technological characteristics:
- Operating Principle Both devices assess Basal Body Temperature. .
- . Temperature Sensor - Both devices use a thermistor sensor.
- Sensor Accuracy The DuoFertility device has a quoted accuracy of +/- 0.05 degrees . Centigrade, and of +/- 0.1 decrees Celsius; OvuSense Fertility Monitor has an accuracy of +/- 0.05 degrees Centigrade. Any potential difference in the accuracy of temperature measurements is not believed to raise any issues of safety, and is a function of the requirements of each devices' algorithms.
- . User Inputs - Both devices have the facility for user input of relevant data.
- Display of Graphs Both devices have the facility for the display of temperature graphs. . The DuoFertility device uses a computer for this display and uses an absolute temperature scale, whilst OvuSense Fertility Monitor uses the OvuSense Reader for
2
pg 3 of 5
display and a relative temperature scale. The different display methodologies do not raise any safety issues, with the relative temperature scale allowing the OvuSense Fertility Monitor user a graph view optimized to their particular temperature readings.
- Number of Measurements Both devices record multiple temperatures. The difference . in any relative number of temperature measurements is not believed to raise any issues of safety, and is simply a function of the requirements of each devices' algorithms.
- Automatic measurements Both devices take measurements automatically. .
- Wireless transfer of data Both devices involve the transfer of data from the Sensor to a . receiving unit.
- Algorithm Both devices use an algorithm to calculate the date of ovulation. The . additional information provided by the OvuSense Fertility Monitor device in respect of absence of ovulation and fertile period prediction is not believed to raise any direct issues of safety, and is employed for increased effectiveness.
The following differences between DuoFertility and OvuSense Fertility Monitor are noted and thus a secondary predicate or reference device - Bioself 2000 is used for substantial equivalence purposes.
- Number of Thermistors The DuoFertility device uses two thermistors plus an . accelerometer/movement Sensor: the OvuSense Fertility Monitor device uses a single thermistor. The Bioself 2000 device uses a single thermistor.
- Location of Thermistor -- The DuoFertility device is worn on the skin: the OvySense . device is placed intravaginally by means of a Personal Sensor. The Bioself 2000 device can be used intravaginally or orally.
The use of two thermistors and an accelerometer (in DuoFertility) versus the use of a single thermistor (OvuSense Fertility Monitor and Bioself 2000) is not believed to raise any direct issues of safety or effectiveness, and the relative location of vaginal versus skin placement is employed by OvuSense Fertility Monitor and Bioself 2000.
NONCLINICAL PERFORMANCE TESTING:
A series of performance tests was conducted in support of the design verification of the Fertility Focus OvuSense Fertility Monitor.
| Summary of Performance Testing Conducted on OvuSense | |
|---|---|
| Biocompatibility | In Vitro Cytotoxicity MEM Elution Assay |
| Mucosal (Vaginal) Irritation Test | |
| Guinea Pig Maximization Sensitization Test | |
| USP Physicochemical Extraction Parameters | |
| ISO Acute Systemic Toxicity Test | |
| In Vitro Mouse Micronucleus Assay – 2 Extracts (ISO) | |
| In Vivo Mouse Micronucleus Assay – 2 Extracts | |
| Bacterial Mutagenicity Test (Ames Assay) | |
| Summary of Performance Testing Conducted on OvuSense | |
| Subchronic (14 day) Intravenous Toxicity Study in Non-Swiss Webster Mice | |
| (14 Repeat Dose Exposure)(GLP) | |
| Subacute (14 day) Intraperitoneal Toxicity Study in Non-Swiss Webster Mice | |
| (14 Repeat Dose Exposure) (GLP) | |
| Exhaustive Extractables | |
| Electrical Testing | EN60601-1-4:2000 Medical electrical equipment. General requirements for |
| safety. Collateral standard. General requirements for electrical programmable | |
| medical systems. | |
| EN60601-1-2:2007 Medical electrical equipment - Part 1-2: General | |
| requirements for basic safety and essential performance - Collateral | |
| standard: Electromagnetic compatibility - Requirements and tests | |
| EN301 489-3 v1.4.1 Electromagnetic Compatibility and Radio Spectrum | |
| Matters (ERM); ElectroMagnetic Compatibility (EMC) Standard for Radio | |
| Equipment and Services; Part 3: Specific Conditions for Short-Range Devices | |
| (SRD) Operating on Frequencies between 9 KHz and 40 GHz | |
| IEC60601-1:2006 Medical equipment. Medical electrical equipment - Part 1: | |
| General requirements for basic safety and essential performance | |
| EN302 291 v1.1.1 Electromagnetic compatibility and Radio spectrum Matters | |
| (ERM); Short Range Devices (SRD); Close Range Inductive Data | |
| Communication equipment operating at 13,56 MHz; Part 2: Harmonized EN | |
| under article 3.2 of the R&TTE Directive | |
| Mechanical | |
| Testing | Tensile (Pull Test) |
| Design | |
| Verification | |
| & Validation | Physical Dimensions, User Cleaning, Reliability for Operating Life, Human |
| Factors-Machine Interface | |
| Cleaning | |
| Validation | Cleaning Validation of Personal Sensor |
Fertility Focus OvuSense Fertility Monitor
3
K122337
CLINICAL TESTING:
Clinical investigation was conducted of the Fertility Focus OvuSense Fertility Monitor from 19 women who participated in a prospective study measuring 81 cycles over 3 months participation.
Traditional 510(k) Fertility Focus
4
pg 5 of 5
The data from the primary endpoint of the trial described in the CIP demonstrated that the OvuSense Fertility Monitor system of ovulation detection provided a biological and statistically significant improvement in ovulation detection compared with the traditional method of oral temperature measurement. It demonstrated good linear agreement with the gold standard detection of ovulation using ultra-sound and an improved 95% confidence interval for the agreement.
CONCLUSION:
Based on the nonclinical verification performance testing and clinical validation, it can be concluded that the Fertility Focus OvuSense Fertility Monitor is equivalent to the DuoFertility Monitor (K102499) and Bioself 2000 (K904211) with respect to intended use, principles of operation, and technological characteristics. The Fertility Focus OvuSense Fertility Monitor has been demonstrated to be as safe, as effective, and performs as well as or better than the predicates.
5
Image /page/5/Picture/1 description: The image shows a logo for the U.S. Department of Health & Human Services. The logo features the department's seal, which includes an emblem with three stylized lines and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged in a circular pattern around the emblem. The text is in uppercase letters.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G60 Silver Spring, MIJ 20993-0002
August 6, 2013
Fertility Focus, Ltd. % Penny Northcutt, RAC, FRAPS, CQA President/CEO REGSolutions, LLC 717 Lakeglen Drive Suwanee, GA 30024
Re: K122337
Trade/Device Name: Fertility Focus OvuSense Fertility Monitor Regulation Number: None Regulation Name: None Regulatory Class: Unclassified Product Code: LHD Dated: July 30, 2013 Received: July 31, 2013
Dear Penny Northcutt,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
6
Page 2 - Penny Northcutt, RAC, FRAPS, CQA
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Glenn Bell -S
for
Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation · Center for Devices and Radiological Health
Enclosure
7
Indications for Use
510(k) Number (if known): K122337
Device Name: Fertility Focus OvuSense Fertility Monitor
Indications for Use:
The Fertility Focus OvuSense Fertility Monitor (Fertility Focus OvuSense Fertility Monitor Starter Kit M009-US, which includes Reader M010-US and Personal Sensor M011) is intended for measuring and recording basal body temperature (BBT) as an aid in ovulation prediction to aid in conception (not to be used for contraception).
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use ___X (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Glenn B. Bell -S
Page 1 of ____________________________________________________________________________________________________________________________________________________________________
(Division Sign-Off) Division of Reproductive, Gastro-Renal, and Urological Devices K122337 510(k) Number _
Traditional 510(k) Fertility Focus
Fertility Focus OvuSense Fertility Monitor